W. Schmidt

Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor.

Kathleen R. Gans, W Galbraith, Richard J. Roman et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 230 citations

Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal Surgery

Conor P. Delaney, James L. Weese, Neil Hyman et al. · Diseases of the Colon & Rectum · 2005 · 218 citations

Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy

Claudia M. Campbell, Mark Kipnes, Bruce C. Stouch et al. · Pain · 2012 · 159 citations · Full text

Pain Therapy, Pain Disorders, Pain Medicine +22

Alvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—A 21-day treatment-randomized clinical trial

Daniel M. Paulson, Daniel Kennedy, Roger A. Donovick et al. · Journal of Pain · 2005 · 157 citations

Gastrointestinal Pharmacology, Pain Medicine, Medicine +7

Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies.

Jéfferson Becker, R. Schwaab, A. Möller-Taube et al. · PubMed · 1996 · 147 citations